Copy Number Variation in Chemokine Superfamily: the Complex Scene of CCL3L-CCL4L Genes in Health and Disease

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2010 Jul 28

PMID 20659124

Citations 24

Authors

R Colobran

E Pedrosa

L Carretero-Iglesia

M Juan

Affiliations

Soon will be listed here.

Abstract

Genome copy number changes (copy number variations: CNVs) include inherited, de novo and somatically acquired deviations from a diploid state within a particular chromosomal segment. CNVs are frequent in higher eukaryotes and associated with a substantial portion of inherited and acquired risk for various human diseases. CNVs are distributed widely in the genomes of apparently healthy individuals and thus constitute significant amounts of population-based genomic variation. Human CNV loci are enriched for immune genes and one of the most striking examples of CNV in humans involves a genomic region containing the chemokine genes CCL3L and CCL4L. The CCL3L-CCL4L copy number variable region (CNVR) shows extensive architectural complexity, with smaller CNVs within the larger ones and with interindividual variation in breakpoints. Furthermore, the individual genes embedded in this CNVR account for an additional level of genetic and mRNA complexity: CCL4L1 and CCL4L2 have identical exonic sequences but produce a different pattern of mRNAs. CCL3L2 was considered previously as a CCL3L1 pseudogene, but is actually transcribed. Since 2005, CCL3L-CCL4L CNV has been associated extensively with various human immunodeficiency virus-related outcomes, but some recent studies called these associations into question. This controversy may be due in part to the differences in alternative methods for quantifying gene copy number and differentiating the individual genes. This review summarizes and discusses the current knowledge about CCL3L-CCL4L CNV and points out that elucidating their complete phenotypic impact requires dissecting the combinatorial genomic complexity posed by various proportions of distinct CCL3L and CCL4L genes among individuals.

Citing Articles

Transcriptional profiles of peripheral eosinophils in chronic obstructive pulmonary disease and asthma-An exploratory study.

Mycroft K, Proboszcz M, Paplinska-Goryca M, Krenke R, Gorska K J Cell Mol Med. 2024; 28(20):e70110.

PMID: 39422548 PMC: 11487681. DOI: 10.1111/jcmm.70110.

Contribution of copy number variations to education, socioeconomic status and cognition from a genome-wide study of 305,401 subjects.

Wu X, Wu B, Kang J, Chen L, Deng Y, Chen S Mol Psychiatry. 2024; 30(3):889-898.

PMID: 39215183 DOI: 10.1038/s41380-024-02717-z.

Monocytic myeloid-derived suppressive cells mitigate over-adipogenesis of bone marrow microenvironment in aplastic anemia by inhibiting CD8 T cells.

Qu Y, Sun Z, Yuan Y, Li Z, Wang F, Wu K Cell Death Dis. 2022; 13(7):620.

PMID: 35851002 PMC: 9293984. DOI: 10.1038/s41419-022-05080-5.

CCL3L3-null status is associated with susceptibility to systemic lupus erythematosus.

Kim Y, Lee E, Sim H, Kang E, Won Y, Lee D Sci Rep. 2021; 11(1):19172.

PMID: 34580371 PMC: 8476559. DOI: 10.1038/s41598-021-98531-6.

Accurate diagnosis and heterogeneity analysis of a 17q12 deletion syndrome family with adulthood diabetes onset and complex clinical phenotypes.

Wu H, Li L, Zhang H, Tang J, Zhang M, Tang H Endocrine. 2021; 73(1):37-46.

PMID: 33745123 DOI: 10.1007/s12020-021-02682-5.

References

Tuzun E, Sharp A, Bailey J, Kaul R, Morrison V, Pertz L . Fine-scale structural variation of the human genome. Nat Genet. 2005; 37(7):727-32. DOI: 10.1038/ng1562. View

Shao W, Tang J, Song W, Wang C, Li Y, Wilson C . CCL3L1 and CCL4L1: variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection. Genes Immun. 2007; 8(3):224-31. DOI: 10.1038/sj.gene.6364378. View

Reymond A, Henrichsen C, Harewood L, Merla G . Side effects of genome structural changes. Curr Opin Genet Dev. 2007; 17(5):381-6. DOI: 10.1016/j.gde.2007.08.009. View

Stankiewicz P, Lupski J . Structural variation in the human genome and its role in disease. Annu Rev Med. 2010; 61:437-55. DOI: 10.1146/annurev-med-100708-204735. View

Fellermann K, Stange D, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins C . A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet. 2006; 79(3):439-48. PMC: 1559531. DOI: 10.1086/505915. View

Yang Y, Chung E, Wu Y, Savelli S, Nagaraja H, Zhou B . Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European.... Am J Hum Genet. 2007; 80(6):1037-54. PMC: 1867093. DOI: 10.1086/518257. View

Bentley R, Pearson J, Gearry R, Barclay M, McKinney C, Merriman T . Association of higher DEFB4 genomic copy number with Crohn's disease. Am J Gastroenterol. 2009; 105(2):354-9. DOI: 10.1038/ajg.2009.582. View

Gorrell M, Gysbers V, McCaughan G . CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand J Immunol. 2001; 54(3):249-64. DOI: 10.1046/j.1365-3083.2001.00984.x. View

McCarroll S, Kuruvilla F, Korn J, Cawley S, Nemesh J, Wysoker A . Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet. 2008; 40(10):1166-74. DOI: 10.1038/ng.238. View

10.

Modi W . CCL3L1 and CCL4L1 chemokine genes are located in a segmental duplication at chromosome 17q12. Genomics. 2004; 83(4):735-8. DOI: 10.1016/j.ygeno.2003.09.019. View

11.

Hughes A, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U . A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet. 2006; 38(10):1173-7. DOI: 10.1038/ng1890. View

12.

Bhattacharya T, Stanton J, Kim E, Kunstman K, Phair J, Jacobson L . CCL3L1 and HIV/AIDS susceptibility. Nat Med. 2009; 15(10):1112-5. DOI: 10.1038/nm1009-1112. View

13.

Graham G, Wright E, Hewick R, Wolpe S, Wilkie N, Donaldson D . Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature. 1990; 344(6265):442-4. DOI: 10.1038/344442a0. View

14.

Dolan M, Kulkarni H, Camargo J, He W, Smith A, Anaya J . CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol. 2007; 8(12):1324-36. DOI: 10.1038/ni1521. View

15.

Colobran R, Comas D, Faner R, Pedrosa E, Anglada R, Pujol-Borrell R . Population structure in copy number variation and SNPs in the CCL4L chemokine gene. Genes Immun. 2008; 9(4):279-88. DOI: 10.1038/gene.2008.15. View

16.

Townson J, Barcellos L, Nibbs R . Gene copy number regulates the production of the human chemokine CCL3-L1. Eur J Immunol. 2002; 32(10):3016-26. DOI: 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D. View

17.

Conrad D, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y . Origins and functional impact of copy number variation in the human genome. Nature. 2009; 464(7289):704-12. PMC: 3330748. DOI: 10.1038/nature08516. View

18.

Guan E, Wang J, Norcross M . Amino-terminal processing of MIP-1beta/CCL4 by CD26/dipeptidyl-peptidase IV. J Cell Biochem. 2004; 92(1):53-64. DOI: 10.1002/jcb.20041. View

19.

Perry G, Dominy N, Claw K, Lee A, Fiegler H, Redon R . Diet and the evolution of human amylase gene copy number variation. Nat Genet. 2007; 39(10):1256-60. PMC: 2377015. DOI: 10.1038/ng2123. View

20.

Zhang F, Gu W, Hurles M, Lupski J . Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet. 2009; 10:451-81. PMC: 4472309. DOI: 10.1146/annurev.genom.9.081307.164217. View